Hi Ocram69
There has been so much said about This subject on another graphite stock in the hundreds of posts a day,enough to destroy ones soul.The sad thing is that the off-takes (Dragon)may well be good and the share Price rose spectacularly on the announcement day, they have been in a down trend ever since, funding issues,due diligence period extensions, Price being forced down each day By half a cent and tricky algorithm patterns,hundreds of down posts each day followed till the market lost faith and it has become a disaster for holders.(Hopefully this may change for them as they have gone in to a trading halt today)Personaly I have listened and learnt from the very people that I was so Frustrated with as some raised very good points which for now I include in my Mantra.
If you want a serious off-take partner you also need one that the funding groups will take serious equally and from the best arguments put forward so far it appears to be western.I am more than happy to be wrong as long as Management leave no money on the table and get the best suited early entry joint venture partner.
1.Bouteque
2.Western Off-take
Hope you do well!
- Forums
- ASX - By Stock
- WKT
- Ann: Project update podcast with Managing Director
Ann: Project update podcast with Managing Director, page-40
Featured News
Add WKT (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.5¢ |
Change
-0.005(4.55%) |
Mkt cap ! $70.48M |
Open | High | Low | Value | Volume |
11.0¢ | 11.0¢ | 10.5¢ | $10.95K | 99.96K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 46500 | 10.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.5¢ | 143782 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 46500 | 0.105 |
5 | 272516 | 0.100 |
1 | 50000 | 0.098 |
2 | 62955 | 0.096 |
6 | 127686 | 0.095 |
Price($) | Vol. | No. |
---|---|---|
0.115 | 143782 | 5 |
0.120 | 201286 | 5 |
0.125 | 165166 | 3 |
0.130 | 202938 | 5 |
0.135 | 148000 | 1 |
Last trade - 15.45pm 24/09/2024 (20 minute delay) ? |
Featured News
WKT (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online